ACOX1 _LIHC.png
Expression analysis of TCGA samples
Basic Information
VIS ID
TVIS10008816
Fusion event
HBV-ACOX1 integration
Validated
No
Detection method
NGS
Data source
Curated
Sample type
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Reported year
2018
PubMed ID
Virus Sequence
Virus name
HBV
Reference genome
Region type
precore/core protein|Core and e antigen|
Start
1932
Orient
+
Integrated sequence
CTGCCTAATCATCTCTTGTTCATGTCCTACTGTTCAAGCCTCCAAGCTGTGCCTTGGGTGGCTTTGGGGCATGGACATCGACCCTTATAAAGAATTTGGA| |GCTACTGTGGAGTTACTCTCGTTTTTGCCTTCTGACTTCTTTCCTTCAGTACGAGATCTTCTAGATACCGCCTCAGCTCTGTATCGGGAAGCCTTAGAGT
Host Sequence
Chromosome
chr17
Cytoband
q25.1
Reference genome
End
73940758/75944677 (Hg38)
Orient
+
Location type
UTR3
Target gene
miRNAs that regulate target gene
hsa-mir-92b-5p ; hsa-mir-615-3p ; hsa-mir-3122 ; hsa-mir-3913-5p ; hsa-mir-155-5p ; hsa-mir-153-5p ; hsa-mir-365b-3p ; hsa-mir-365a-3p ; hsa-mir-1273e ; hsa-mir-650 ; hsa-mir-3612 ; hsa-mir-2467-3p ; hsa-mir-1827 ; hsa-mir-219b-3p ; hsa-mir-4649-3p ; hsa-mir-1247-3p ; hsa-mir-3919 ; hsa-mir-6511a-5p ; hsa-mir-1910-3p ; hsa-mir-3123 ; hsa-mir-302f ; hsa-mir-6513-5p ; hsa-mir-887-5p ; hsa-mir-450a-1-3p ; hsa-mir-6796-5p ; hsa-mir-7109-5p ; hsa-mir-7977 ; hsa-mir-6742-5p ; hsa-mir-4472 ; hsa-mir-4447 ; hsa-mir-3151-5p ; hsa-mir-491-5p ; hsa-mir-6885-5p ; hsa-mir-328-5p ; hsa-mir-6887-5p ; hsa-mir-6795-5p ; hsa-mir-5196-5p ; hsa-mir-4747-5p ; hsa-mir-383-3p ; hsa-mir-595 ; hsa-mir-7855-5p ; hsa-mir-548s ; hsa-mir-3926 ; hsa-mir-3190-5p ; hsa-mir-6849-3p ; hsa-mir-4433a-3p ; hsa-mir-4459 ; hsa-mir-4768-3p ; hsa-mir-6516-5p ; hsa-mir-455-3p ; hsa-mir-6807-5p ; hsa-mir-6788-3p ; hsa-mir-6499-3p ; hsa-mir-4474-3p ; hsa-mir-24-3p ; hsa-mir-4284 ; hsa-mir-6787-3p ; hsa-mir-342-3p ; hsa-mir-3065-3p ; hsa-mir-1228-3p ; hsa-mir-216b-5p ; hsa-mir-216a-5p ; hsa-mir-619-5p ; hsa-mir-5004-3p ; hsa-mir-4665-3p ; hsa-mir-636 ; hsa-mir-6778-3p ; hsa-mir-150-5p ; hsa-mir-7107-5p ; hsa-mir-1234-3p ; hsa-mir-186-3p ; hsa-mir-520h ; hsa-mir-520g-3p ; hsa-mir-520f-3p ; hsa-mir-302c-3p ; hsa-mir-520e ; hsa-mir-520d-3p ; hsa-mir-520c-3p ; hsa-mir-520b ; hsa-mir-520a-3p ; hsa-mir-373-3p ; hsa-mir-372-3p ; hsa-mir-302e ; hsa-mir-302d-3p ; hsa-mir-302b-3p ; hsa-mir-302a-3p ; hsa-mir-93-5p ; hsa-mir-526b-3p ; hsa-mir-519d-3p ; hsa-mir-20b-5p ; hsa-mir-20a-5p ; hsa-mir-17-5p ; hsa-mir-106b-5p ; hsa-mir-106a-5p ; hsa-mir-195-5p ; hsa-mir-16-5p ; hsa-mir-15b-5p ; hsa-mir-15a-5p ; hsa-mir-1293 ; hsa-mir-3165 ; hsa-mir-339-5p ; hsa-mir-363-5p ; hsa-mir-4421 ; hsa-mir-4483 ; hsa-mir-5699-3p ; hsa-mir-6134 ; hsa-mir-6745 ; hsa-mir-6748-5p ; hsa-mir-6756-5p ; hsa-mir-6766-5p ; hsa-mir-6769a-5p ; hsa-mir-6769b-5p ; hsa-mir-6771-3p
Nearest miRNA
hsa-mir-10226/Upstream/160070; hsa-mir-1250/Downstream/153342;
Upstream sequence
CTAAATTTCTTCATAATTTAAACCTATGTTTAGTTGTGTGGCATATTTTTTCTCTCTTAATAGTACAAATCAGTGACGTTTACTCTATCTTTATTCTTGA
Downstream sequence
TTATATTGAATAAAGTTCAAGACAGAACATTCCAATATTAATAAAAATAGCATCAAATGTCAGATTTAGAttttttttttgagacggagtctcgctcagc
Reference
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.
Curate